Skip to main content
Premium Trial:

Request an Annual Quote

That's One Way to Cut Down on Negative Findings

The New York Times reports on a complaint filed by academic researchers who say that biotech companies are preventing them from "fully researching the effectiveness and environmental impact of the industry's genetically modified crops," the article says. (You can also check out the statement they submitted to EPA.) "The problem, the scientists say, is that farmers and other buyers of genetically engineered seeds have to sign an agreement meant to ensure that growers honor company patent rights and environmental regulations. But the agreements also prohibit growing the crops for research purposes," the story says.

According to the Times, EPA will be holding scientific meetings on biotech crops this week, and is looking for public comment on this topic.

Stephen Albainy-Jenei at Patent Baristas blogs about the issue as well, noting that while scientists looking to study these crops "can ask for permission from the seed companies, permission is sometimes denied or the company insists on the right to have an advance review of the studies' results before they can be published."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.